Track topics on Twitter Track topics that are important to you
PreveCeutical Medical Inc. (CSE:PREV) (OTCQB PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that the Company's research collaboration with UniQuest and The University of Queensland ("UQ") has led to the filing of two new patent applications for cyclic peptides and their use in pain management (the "Patent Applications").
The post PreveCeutical Partnership Leads to Two New Patent Filings appeared first on Investing News Network.
Original Article: PreveCeutical Partnership Leads to Two New Patent FilingsNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...